Skip NavigationSkip to Content

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability

  1. Author:
    Shi, Wei
    Wang, Lingshu
    Zhou, Tongqing
    Sastry, Mallika
    Yang, Eun Sung
    Zhang, Yi
    Chen, Man
    Chen, Xuejun
    Choe, Misook
    Creanga, Adrian
    Leung, Kwan
    Olia, Adam S
    Pegu, Amarendra
    Rawi, Reda
    Schön, Arne
    Shen, Chen-Hsiang
    Stancofski, Erik-Stephane D
    Talana, Chloe Adrienna
    Teng, I-Ting
    Wang, Shuishu
    Corbett, Kizzmekia S
    Tsybovsky,Yaroslav
    Mascola, John R
    Kwong, Peter D
  2. Author Address

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA., Electron Microscopy Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: jmascola@icloud.com., Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: pdkwong@nih.gov.,
    1. Year: 2022
    2. Date: Jul 12
    3. Epub Date: 2022 07 12
  1. Journal: Structure (London, England : 1993)
    1. 30
    2. 9
    3. Pages: 1233–1244
  2. Type of Article: Article
  1. Abstract:

    Immunization with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike elicits diverse antibodies, but it is unclear if any of the antibodies can neutralize broadly against other beta-coronaviruses. Here, we report antibody WS6 from a mouse immunized with mRNA encoding the SARS-CoV-2 spike. WS6 bound diverse beta-coronavirus spikes and neutralized SARS-CoV-2 variants, SARS-CoV, and related sarbecoviruses. Epitope mapping revealed WS6 to target a region in the S2 subunit, which was conserved among SARS-CoV-2, Middle East respiratory syndrome (MERS)-CoV, and hCoV-OC43. The crystal structure at 2 Å resolution of WS6 revealed recognition to center on a conserved S2 helix, which was occluded in both pre- and post-fusion spike conformations. Structural and neutralization analyses indicated WS6 to neutralize by inhibiting fusion and post-viral attachment. Comparison of WS6 with other recently identified antibodies that broadly neutralize beta-coronaviruses indicated a stem-helical supersite-centered on hydrophobic residues Phe1148, Leu1152, Tyr1155, and Phe1156-to be a promising target for vaccine design. Published by Elsevier Ltd.

    See More

External Sources

  1. DOI: 10.1016/j.str.2022.06.004
  2. PMID: 35841885
  3. PMCID: PMC9284671
  4. PII : S0969-2126(22)00235-0

Library Notes

  1. Fiscal Year: FY2021-2022
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel